Literature DB >> 33629244

Improved risk-stratification in heart failure patients with mid-range to severe abnormalities of QRS duration and systolic function using mechanical dyssynchrony assessed by myocardial perfusion-gated SPECT.

Takahiro Doi1, Tomoaki Nakata2, Takahiro Noto3, Tomohiro Mita3, Satoshi Yuda3, Akiyoshi Hashimoto4.   

Abstract

BACKGROUND: The use of left ventricular mechanical dyssynchrony (LVMD), which has been reported to be responsible for unfavorable outcomes, might improve conventional risk-stratification by clinical indices including QRS duration (QRSd) and systolic dysfunction in patients with heart failure (HF). METHODS AND
RESULTS: Following measurements of 12-lead QRSd and left ventricular ejection fraction (LVEF), three-dimensional (3-D) LVMD was evaluated as a standard deviation (phase SD) of regional mechanical systolic phase angles by gated myocardial perfusion imaging in 829 HF patients. Patients were followed up for a mean period of 37 months with a primary endpoint of lethal cardiac events (CEs). In an overall multivariate Cox proportional hazards model, phase SDs were identified as significant prognostic determinants independently. The patients were divided into 4 groups by combining with the cut-off values of LVEF (35% and 50%) and QRSd (130 ms and 150 ms). The groups with lower LVEF and prolonged QRSd more frequently had CEs than did the other groups. Patient groups with LVEF < 35% and with 35% ≦ LVEF < 50% were differentiated into low-risk and high-risk categories by using an optimal phase SD cut-off value of both QRSd thresholds.
CONCLUSIONS: 3-D LVMD can risk-stratify HF patients with mid-range as well as severe abnormalities of QRSd and systolic dysfunction.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Heart failure; Left ventricular mechanical dyssynchrony; Prognosis; QRS duration; Risk-stratification

Mesh:

Year:  2021        PMID: 33629244     DOI: 10.1007/s12350-021-02554-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  2 in total

1.  Three-dimensional left ventricular mechanical dyssynchrony assessed by myocardial perfusion gated-SPECT: Is there a role in cardiac resynchronization therapy?

Authors:  Cinzia Valzania; Riccardo Mei; Mauro Biffi
Journal:  J Nucl Cardiol       Date:  2021-04-16       Impact factor: 3.872

2.  Left ventricular mechanical dyssynchrony in patients with heart failure: What is the next step?

Authors:  Feifei Zhang; Yuetao Wang
Journal:  J Nucl Cardiol       Date:  2021-03-11       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.